Famotidine versus pantoprazole.
Lwin
Aung A
AA
D053799:2-Pyridinylmethylsulfinylbenzimidazoles / Q000627:therapeutic use*; D016638:Critical Illness; D015738:Famotidine / Q000627:therapeutic use*; D006635:Histamine H2 Antagonists / Q000627:therapeutic use*; D006801:Humans; D000077402:Pantoprazole; D010438:Peptic Ulcer Hemorrhage / Q000209:etiology / Q000517:prevention & control*; D054328:Proton Pump Inhibitors / Q000627:therapeutic use*; D012121:Respiration, Artificial / Q000009:adverse effects
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D006635:Histamine H2 Antagonists; D054328:Proton Pump Inhibitors; D015738:Famotidine; D000077402:Pantoprazole